Matthijs Versteegh

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (7)

Apostolos Tsiachristas

University of Oxford

UNITED KINGDOM

View details

Pieter van Baal

Erasmus University Rotterdam

NETHERLANDS

View details

Arthur Attema

Associate Professor

Erasmus University Rotterdam

NETHERLANDS

View details

Werner Brouwer

professor of health economics (as of 2008)

Erasmus University Rotterdam

NETHERLANDS

View details

Stefan Lipman

Erasmus Universiteit Rotterdam Erasmus School of Health Policy and Management

NETHERLANDS

View details

Maureen P. M. H. Rutten-van Mölken

Erasmus University Rotterdam

NETHERLANDS

View details

Sarah Wordsworth

Professor

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthijs Versteegh

Research Interests

Explore related searches

Contact this professor

Articles (10)

Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies

Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK

Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries

Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation

Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems

The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice

Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young

Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale

Correcting for discounting and loss aversion in composite time trade‐off

Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020

Collaborators (7)

Apostolos Tsiachristas

Pieter van Baal

Arthur Attema

Werner Brouwer

Stefan Lipman

Maureen P. M. H. Rutten-van Mölken

Sarah Wordsworth

Make your next move.